Title : Iron Supplementation Improves Cardiovascular Outcomes in Patients with Heart Failure.

Pub. Date : 2019 Aug

PMID : 30853478






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Moreover, serum levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) were markedly decreased in patients with iron repletion compared with placebo treatment (WMD: -332.48 pg/mL; 95% CI, -497.48 to -167.47; WMD: -4.64 mg/L; 95% CI, -6.12 to -3.17, respectively). Iron C-reactive protein Homo sapiens
2 Moreover, serum levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) were markedly decreased in patients with iron repletion compared with placebo treatment (WMD: -332.48 pg/mL; 95% CI, -497.48 to -167.47; WMD: -4.64 mg/L; 95% CI, -6.12 to -3.17, respectively). Iron C-reactive protein Homo sapiens
3 CONCLUSIONS: Our meta-analysis suggests that iron therapy can reduce heart failure hospitalization, increase cardiac function, improve quality of life, and decrease serum levels of NT-proBNP and CRP in patients with heart failure. Iron C-reactive protein Homo sapiens